Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on ARM HOLDINGS PLC. We currently have 9 research reports from 3 professional analysts.
|05Sep16 15:29||RNS||Form 8.3 - ARM Holding Plc|
|05Sep16 15:20||RNS||Form 8.3 - ARM Holdings Plc|
|05Sep16 14:29||RNS||Appointment of directors to ARM Holdings plc|
|05Sep16 12:10||RNS||Form 8.3 - ARM Holdings Plc|
|05Sep16 12:00||RNS||Form 8.5 (EPT/RI)|
|05Sep16 11:57||RNS||Form 8.5 (EPT/RI)|
|05Sep16 11:54||RNS||Form 8.5 (EPT/NON-RI)|
Frequency of research reports
Research reports on
ARM HOLDINGS PLC
ARM HOLDINGS PLC
28 Jul 16
"The FOMC delivered much as expected. Rates were left on hold but, by stating that 'Near-term risks to the economic outlook risks have diminished', the door has been left open for its first rate hike since December 2015 with the hot money remaining on +25bp in September and another +25bp before the year end. Lacking new excitement, London equities are expected to open marginally down, with the FTSE-100 seen down between 5 and 10 points in early trade. US markets closed in a similar mood, with the Dow and S&P 500 left virtually unchanged, leaving only the technology-heavy NASDAQ celebrating better than expected results from Apple following the previous close. Sentiment in Asia continued to yo-yo on the longawaited Japanese stimulus package, forcing the Nikkei to give back half of yesterday's gains, while the Shanghai Composite remained nervous amid threats of new regulation on wealth management products, leaving only the commoditydominated ASX enjoying a small positive by the close. Amongst UK corporates, investors are now able to put a figure on the cost to BHP Billiton (BLT.L) shareholders over the Samarco Dam disaster, with the company indicating a US$1.1bn to US$1.3bn provision, while in yesterday's statement GSK's (GSK.L) Board suggested the post-Brexit fall in Sterling presents a mix of new challenges to the Group. This morning, UK markets anticipate release of the Nationwide House Price Index along with a heavy clutch of results including, Anglo American (AAL.L), AstraZeneca (AZN.L), BAE (BA..L), Centrica (CNA.L), Diageo (DGE.L), Rolls Royce (RR..L), Royal Dutch Shell (RDSA.L) and Weir Group (WEIR.L)." - Barry Gibb, Research Analyst
19 Jul 16
"With few significant new stories emerging overnight, equities in London will probably give back some of the M&A inspired gains recorded yesterday following Softbank's generous cash offer for UK technology stock, ARM Holdings. With crude oil prices seemingly stuck around their two-month low on continuing concerns of a glut in the face of much predicted slowing economic activity, the FTSE-100 is seen opening around 23 points lower this morning. US equity markets all gained modestly once again, leaving the Dow Jones with another record closing on Monday led mainly by financials, while the tech-heavy NASDAQ put in the best gains of the session. Asia closed mixed, with the Nikkei chalking up its sixth consecutive gain on Tuesday as it resumed trading after Friday's public holiday amid continuing anticipation its government's pending provision of new economic stimulation, although heavily indebted Softbank was sharply sold off on concerns that it may be overpaying for its proposed acquisition. Elsewhere, Chinese and Korean stocks weakened while Australia's commodity heavy market remained quiet with light trading. Today in London, politicians and lawmakers will continue heated discussions regarding the UK's proposed renewal of its Trident nuclear programme, while the Financial Stability Oversight Council will again discuss the effects of future actions to effect Brexit. Data watchers should anticipate UK Inflation and producer price data, along with release of the national House Price Index. No major corporates are due to release results this morning, although a trading update is expected from Royal Mail." - Barry Gibb, Research Analyst
ARM acquired by Softbank, putting the IoT back under the spotlight
18 Jul 16
ARM is about to be acquired by the Japanese conglomerate Softbank for £24.3bn in cash, corresponding to £17 per share, or a 43% premium. It must be approved by at least 75% of the shareholders, and according to the official announcement is not subject to any anti-trust or regulatory conditions before closing. The closing of the deal is expected by no later than 17 November 2016.
19 May 16
London equities are set for a relatively sharp decline on this morning's opening, with the FTSE-100 seen down as much as 1%, or around 60 points, during first trades. Driving this are the concerns expressed by the Federal Open Market Committee yesterday afternoon, which left investors with a sharp warning that an interest-rate increase is still a possible outcome from June's policy meeting should the domestic economy sustain its recent improvement. Fed Policy makers also raised additional concerns about the scope of their macroprudential tools required to sustain financial stability across the broader US economy. Japan and China made modest gains overnight, while most other Asian markets recorded small losses as investors similarly reflected on the cautions contained in the Fed minutes. Today, investors should expect UK retail sales data and the release of ECB policy meeting minutes, followed by US leading indicators, weekly jobless claims and a speech by Fed's Dudley this afternoon. Results are expected from 3i, Booker, Britvic, Investec, National Grid, Royal Mail andThomas Cook.
Royalties above expectations, as well as opex
20 Apr 16
ARM reported Q1 revenues of $398m, a 2.4% sequential decrease but an increase of 14.3% yoy. In sterling, revenues reached £276.4m, corresponding respectively to a sequential increase of 2.7% and 25.4% yoy. Licensing revenues have increased by 11.3% yoy to $148.3m, for a 6.4% sequential decrease, while royalty revenues were flat sequentially and increased by 16.8% yoy to $215.7m. Thirty-nine licences have been signed during the quarter, of which four were v8. The gross margin reached 96.5%, a slight increase (+20bp) on the previous quarter. The normalised operating margin came in at 48.6%, a 190bp sequential decrease caused once again by a substantial jump in operating expenses (£132.9m vs. £123.9m), while the IFRS operating margin reached 39.7%, down 130bp sequentially and 490bp yoy. This led to a normalised profit before tax of £137.5m (£112m in IFRS). Due to the current slowdown in the smartphone market, the company expects the full-year 2016 dollar top-line to grow by c. 7.5%.
20 Feb 17
Hayward Tyler Group* (HAYT): Trading update and financial position (CORP) | Petra Diamonds (PDL): Interim results (BUY) | Gemfields* (GEM): Interim results (CORP) | Premaitha Health* (NIPT): Middle East momentum (CORP) | Sound Energy (SOU): Acquisition update and TE-8 well spud (HOLD) | Proactis* (PHD): Interim trading on track (CORP) | 7digital* (7DIG): Automotive contract win (CORP)
The Slide Rule
12 Jan 17
What is The Slide Rule? The Slide Rule has been designed to dramatically simplify the identification of the best companies in the UK small/mid-cap sector by making a quantitative assessment of the relative potential of each company. At its core, The Slide Rule aims to identify those companies that create genuine shareholder value through strong returns on capital and solid growth, but also present a value opportunity with the potential tailwind of earnings momentum. Companies are assessed within a Quality, Value, Growth and Momentum (QVGM) framework.
13 Feb 17
Middlesbrough-based pawnbroker Ramsdens Holdings is set to join AIM on 15 February. Its growth is not coming from its core business but from providing foreign currency, pre-paid travel cards and international payments. The strategy is to increase the group’s online activities and grow the number of branches. In the year to March 2016, group revenues improved from £29.2m to £30m. The accounts of the main subsidiary show that foreign-currency margin rose from £5.36m to £7.59m. This contributes 35% of group gross profit. By contrast, the core business of pawnbroking, precious metal purchases and retail sales fell from £21.3m to £19.8m. Revenues from other financial services were flat at £2.6m. Ramsdens has 127 sites and last year it made an operating profit of £3.19m. In the six months to September 2016, revenues increased from £16.2m to £18.4m and operating profit improved from £2.81m to £3.48m. The placing will raise £15.6m at 86p a share, valuing the company at £26.5m. NorthEdge Capital, which backed a buyout in September 2014, will receive just over £10m from share sales. The NorthEdge stake will fall from 75.6% to 30.7%. The other £5m will go to the company and be used to repay the remaining loan notes and the costs of the flotation. By the end of March 2016, there were still £4m of loan notes outstanding to NorthEdge, with £4.86m paid off during the previous year.
13 Feb 17
Surface Transforms* (SCE): H1 results confirm operational progress (CORP) | Premaitha Health* (NIPT): European diagnostics partnership (CORP) | Lok'nStore* (LOK): Filling existing stores, developing new ones (CORP) | Victoria* (VCP): Entry into the European flooring market (CORP) | eg solutions* (EGS): Exceptional H2 performance (CORP)
Share & share alike
14 Feb 17
The rally in the last fortnight, highlighted in the table, reflects a continued flow of positive updates and economic news. The FTSE 250, Small cap and Fledgling indices have reached record highs. We are in the lull ahead of results for those companies with a December year end, a welter of economic data regarding the UK economy, the State of the Union address in the US on 28 February and the UK Budget on Wednesday 8 March. We will learn at that stage the latest forecasts from the Office of Budget Responsibility. As highlighted previously, the reaction to corporate updates will continue to set the tone.
Small Cap Breakfast
14 Feb 17
Xafinity –Publication of prospectus. The pensions actuarial, consulting and administration business has conditionally raised £179.6m. At 139p. Due to join main market 16 Feb. Guinness Oil & Gas Exploration—Publication of prospectus. Seeking to raise £50m and invest in 15 exploration companies at launch, with plans to grow the portfolio to 30 positions during its lifetime. Issue closing 23 Feb. Arix Bioscience — Intention to float on the main market from the global healthcare and life science company supporting medical innovation. Raised £52m in Feb 16 with investors including Woodford Investment Management Ramsdens Holdings –Schedule One from the financial services provider and retailer, operating in the core business segments of foreign currency exchange, pawnbroking loans, precious metals buying and selling and retailing of second hand and new jewellery. Expected admission to AIM 15 Feb raising circa £15.6m. Expected mkt cap £26.5m.